We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+16.29%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.82B
AUM Growth
+$1.31B
Cap. Flow
+$158M
Cap. Flow %
2.03%
Top 10 Hldgs %
19.27%
Holding
869
New
65
Increased
350
Reduced
240
Closed
81

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$43.7M
2
BMY icon
Bristol-Myers Squibb
BMY
+$30.4M
3
GILD icon
Gilead Sciences
GILD
+$28.3M
4
BIIB icon
Biogen
BIIB
+$26.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$25.2M

Sector Composition

Rank Sector Weight
1 Healthcare 33.36%
2 Technology 15.96%
3 Financials 11.25%
4 Consumer Discretionary 8.98%
5 Communication Services 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCF
201
DELISTED
TCF Financial Corporation
TCF
$9.46M 0.12%
+457,164
New +$9.97M
CVS icon
202
CVS Health
CVS
$137B
$9.43M 0.12%
154,875
-5,727
-4% -$353K
TYL icon
203
Tyler Technologies
TYL
$12.2B
$9.31M 0.12%
45,527
+31,412
+223% +$6.22M
VIAB
204
DELISTED
Viacom Inc. Class B
VIAB
$9.2M 0.12%
327,691
+87,657
+37% +$2.52M
NTR icon
205
Nutrien
NTR
$32.7B
$9.2M 0.12%
174,347
-73,148
-30% -$3.81M
CVX icon
206
Chevron
CVX
$388B
$9.18M 0.12%
74,548
-103,463
-58% -$12.2M
RY icon
207
Royal Bank of Canada
RY
$291B
$9.07M 0.12%
120,186
-8,716
-7% -$659K
IPG
208
DELISTED
Interpublic Group of Companies
IPG
$9.06M 0.12%
431,231
+391,611
+988% +$8.72M
CFG icon
209
Citizens Financial Group
CFG
$30.4B
$9.06M 0.12%
278,715
+78,787
+39% +$2.73M
ITUB icon
210
Itaú Unibanco
ITUB
$91.3B
$9.01M 0.12%
1,405,375
-575,981
-29% -$4.07M
RHT
211
DELISTED
Red Hat Inc
RHT
$8.96M 0.11%
49,060
-739
-1% -$132K
ICPT
212
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$8.95M 0.11%
+80,000
New +$8.74M
AMT icon
213
American Tower
AMT
$77.7B
$8.94M 0.11%
45,353
+1,571
+4% +$276K
FDX icon
214
FedEx
FDX
$74.5B
$8.92M 0.11%
49,171
+27,285
+125% +$4.82M
XEC
215
DELISTED
CIMAREX ENERGY CO
XEC
$8.92M 0.11%
127,547
+117,069
+1,117% +$8.42M
RF icon
216
Regions Financial
RF
$26.3B
$8.82M 0.11%
623,244
+29,467
+5% +$451K
OLED icon
217
Universal Display
OLED
$3.71B
$8.8M 0.11%
57,574
-42,279
-42% -$5.23M
EIX icon
218
Edison International
EIX
$30.7B
$8.78M 0.11%
141,736
-59,111
-29% -$3.53M
LEA icon
219
Lear
LEA
$7.19B
$8.75M 0.11%
64,468
+22,457
+53% +$3.29M
MU icon
220
Micron Technology
MU
$1.04T
$8.57M 0.11%
184,429
-21,425
-10% -$828K
CERN
221
DELISTED
Cerner Corp
CERN
$8.54M 0.11%
149,306
+47,949
+47% +$2.67M
GGAL icon
222
Galicia Financial Group
GGAL
$7.92B
$8.5M 0.11%
333,000
+124,000
+59% +$3.89M
AFL icon
223
Aflac
AFL
$63.9B
$8.41M 0.11%
106,225
+7,207
+7% +$347K
QCOM icon
224
Qualcomm
QCOM
$176B
$8.32M 0.11%
145,869
-33,860
-19% -$1.83M
USB icon
225
US Bancorp
USB
$99.6B
$8.29M 0.11%
146,121
+1,302
+0.9% +$65.3K

Similar funds

Candriam SCA's Q1 2019 Portfolio in Review

As of Q1 2019, Candriam SCA held 869 positions worth $7.82B, up 20% from $6.51B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA's Q1 2019 filing shows 65 new, 350 increased, 240 reduced and 81 closed positions. Its largest new stake was Baozun: 640,000 shares worth $26.6M. The largest sale was Celgene Corp, an estimated $75.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2019 buy was Baozun: 640,000 shares worth $26.6M.
  • Candriam SCA added most to Merck in Q1 2019, an estimated $43.7M increase.
  • Candriam SCA's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $75.2M.
  • Candriam SCA fully exited Loxo Oncology, Inc in Q1 2019, selling an estimated $28.1M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.82B portfolio in Q1 2019.
  • Candriam SCA opened 65 new positions and closed 81 in Q1 2019.
  • Candriam SCA's portfolio value rose 20% quarter-over-quarter to $7.82B.

Based on Candriam SCA's 13F filing for Q1 2019, filed 2 May 2019.